SCHEMBL12278571

SCHEMBL12278571

Cc1cc2cc3ccc4c5cc6oc(C)cc6cc5ccc4c3cc2o1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PIM1 P11309 2/20 0.42
▸ CSNK2A1 P68400 2/20 0.42
▸ CSNK2A2 P19784 1/20 0.42
▸ CSNK2B P67870 1/20 0.42
▸ CSNK2A3 Q8NEV1 1/20 0.42
▸ DYRK1A Q13627 1/20 0.41
▸ CYP1A2 P05177 7/20 0.36
▸ CYP1A1 P04798 6/20 0.36
▸ CYP1B1 Q16678 5/20 0.36
▸ HPGD P15428 3/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ ADORA3 P0DMS8 1/20 0.34
▸ THRB P10828 1/20 0.34
▸ MAPK1 P28482 1/20 0.34
▸ HSD17B10 Q99714 3/20 0.33
▸ GAA P10253 3/20 0.33
▸ ALDH1A1 P00352 2/20 0.33
▸ NPC1 O15118 1/20 0.33
▸ MGAM O43451 1/20 0.33
▸ SI P14410 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18177588 0.96 PIM1 (0.44) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL12277922 0.92 DYRK1A (0.41) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL12277878 0.88 CYP3A4 (0.47) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL12277888 0.85 EPHX2 (0.38) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL19486063 0.85 DYRK1A (0.44) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL12277889 0.81 CYP3A4 (0.44) DYRK1ACYP1A1HPGDCYP3A4ADORA3
SCHEMBL18177607 0.79 PIM1 (0.35) PIM1CSNK2A1CSNK2A2CSNK2BCSNK2A3
SCHEMBL4419972 0.79 DYRK1A (0.45) DYRK1ACYP1A2CYP1A1CYP1B1HPGD
SCHEMBL12277944 0.78 EPHX2 (0.38) DYRK1ACYP1A2CYP1A1CYP1B1HPGD
SCHEMBL25165205 0.77 DYRK1A (0.44) DYRK1ACYP1A2CYP1A1CYP1B1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8785915-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-07-22 — — US disclosed
US-8785915-B2 Compound for organic thin film transistor and organic thin film transistor using the same IDEMITSU KOSAN CO., LTD. (JP) 2014-07-22 — — US disclosed
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) 2011-09-01 — — US disclosed
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME COMPOUND FOR ORGANIC THIN FLIM TRANSISTOR AND ORGANIC THAN FLIM TRANSITOR USING THE SAME (JP) 2011-09-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110210319-A1 COMPOUND FOR ORGANIC THIN FILM TRANSISTOR AND ORGANIC THIN FILM TRANSISTOR USING THE SAME OR10J3, TCF4, CTCF PIM1 2242/4885CSNK2A1 4675/4885CSNK2A2 4570/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback